Untreated Flt3 Mutated Acute Myeloid Leukemia clinical trials

Explore recruiting untreated flt3 mutated acute myeloid leukemia clinical trials.

Also recruiting in Europe

Untreated Flt3 Mutated Acute Myeloid Leukemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase II, open-label, single arm study to evaluate the safety, efficacy, and pharmacokinetics of twice daily midostaurin (PKC412) combined with standard chemotherapy and as a single agent post-consolidation therapy in children with untreated FLT3-mutated AML

Germany, Poland, Slovenia, Czechia, Austria, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Untreated Flt3 Mutated Acute Myeloid Leukemia trials by city

Untreated Flt3 Mutated Acute Myeloid Leukemia in Toronto Untreated Flt3 Mutated Acute Myeloid Leukemia in Vancouver Untreated Flt3 Mutated Acute Myeloid Leukemia in Montreal Untreated Flt3 Mutated Acute Myeloid Leukemia in Calgary Untreated Flt3 Mutated Acute Myeloid Leukemia in Edmonton Untreated Flt3 Mutated Acute Myeloid Leukemia in Ottawa Untreated Flt3 Mutated Acute Myeloid Leukemia in Winnipeg Untreated Flt3 Mutated Acute Myeloid Leukemia in Quebec City Untreated Flt3 Mutated Acute Myeloid Leukemia in Hamilton Untreated Flt3 Mutated Acute Myeloid Leukemia in Kitchener Untreated Flt3 Mutated Acute Myeloid Leukemia in London Untreated Flt3 Mutated Acute Myeloid Leukemia in Halifax Untreated Flt3 Mutated Acute Myeloid Leukemia in New York Untreated Flt3 Mutated Acute Myeloid Leukemia in Los Angeles Untreated Flt3 Mutated Acute Myeloid Leukemia in Chicago Untreated Flt3 Mutated Acute Myeloid Leukemia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease